Repare Therapeutics Inc. (RPTX) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-01-30

Repare Therapeutics Inc. (RPTX) — no SEC Form 4 insider filings recorded in the last 90 days. InsiderAlpha tracks every RPTX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Repare Therapeutics Inc. (RPTX)

SEC CIK	0001808158

Recent RPTX Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-01-28	SCHAFER CAROL	Insider	D — Derivative transaction	8.0K	—	—	SEC
2026-01-28	RHOADS ANN D	Insider	D — Derivative transaction	4.0K	—	—	SEC
2026-01-28	Civik Thomas	Insider	D — Derivative transaction	7.5K	—	—	SEC
2026-01-28	Forte Steve	EVP, CHIEF FINANCIAL OFFICER	D — Derivative transaction	56.8K	—	—	SEC
2026-01-28	Alves Sandra Isabelle Barros	SVP, Finance and CAO	D — Derivative transaction	31.6K	—	—	SEC
2026-01-28	BVF PARTNERS L P/IL	10% Owner	J — Other acquisition / disposition	5.31M	—	—	SEC
2026-01-28	BVF PARTNERS L P/IL	10% Owner	J — Other acquisition / disposition	4.31M	—	—	SEC
2026-01-28	BVF PARTNERS L P/IL	10% Owner	J — Other acquisition / disposition	548.9K	—	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Repare Therapeutics Inc. (RPTX). Updated in real time as new filings are submitted to the SEC.

Recent Insider Filings

2026-01-30 — BVF PARTNERS L P/IL (10% Owner)
2026-01-29 — SCHAFER CAROL (Insider)
2026-01-29 — RHOADS ANN D (Insider)
2026-01-29 — Civik Thomas (Insider)
2026-01-29 — Forte Steve (EVP, CHIEF FINANCIAL OFFICER)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in RPTX insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

RPTX Insider Trading — FAQ

What is the latest insider trade for RPTX?: Repare Therapeutics Inc. (RPTX) had 0 insider filings in the last 90 days, with the most recent on 2026-01-30. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying RPTX stock?: 0 insider purchases of RPTX were filed in the last 90 days.
How many insiders are selling RPTX stock?: 0 insider sales of RPTX were filed in the last 90 days.
Where can I see RPTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every RPTX SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live RPTX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.